Biomedical subjects
M Gai
Publications and source records attributed to M Gai.
Collective band structure and origin of enhanced E1 decays in 18O.
Explore the source record for details and available documents.
Beta decay of 18N to alpha particle emitting states in 18O and a proposed search for parity violation in 18O.
Explore the source record for details and available documents.
Local deviations from the Grodzins systematics: Enhanced collectivity in the transitional Ra-Th nuclei.
Explore the source record for details and available documents.
Yrast states of 216Rn and the extent of a region of possible static intrinsic reflection asymmetry.
Explore the source record for details and available documents.
Spectroscopy of 18O: Radiative capture, 14C( alpha, gamma )18O.
Explore the source record for details and available documents.
Level spectrum of 219Ra and weak coupling in the light actinide region.
Explore the source record for details and available documents.
Intermediate and weak coupling in 219Ra.
Explore the source record for details and available documents.
Interplay of resonant and l-window background amplitudes in 16O+16O.
Explore the source record for details and available documents.
Level structure of 220Ra.
Explore the source record for details and available documents.
[Serum prostatic acid phosphatase].
Explore the source record for details and available documents.
[Findings on proteinuria in selected diabetic patients. Relation to microangiopathy and its prognostic significance].
Urinary protein is usually above normal in diabetics, even when the disease is of recent onset. Values tend to move further away from physiological levels as the condition persists. Electrophoresis reveals a selective glomerular form, even in many subjects with a quantitatively normal picture and free of signs of micro- and macroangiopathy, as these are commonly defined, whereas non-selective glomerular proteinuria is observed in patients with micro- or macroangiopathic lesions, such as marked changes in renal clearance, intense proteinuria, hypertension, chronic renal failure. It is suggested that careful evaluation of urinary proteins can be usefully associated with examination of the fundus to obtain early warning of microangiopathic lesions in the two target organs, i.e. the kidneys and retinae.
Modelling the "ideal" self care--limited care dialysis center.
Limited care dialysis is an interesting option, which has gained attention in several settings because of the aging of the uremic cohort. The aim of this study was to assess its potential in the Piedmont region in northern Italy, evaluating patients' and care-givers' preferences and testing them in a mathematical model of organisation. The study was conducted in the satellite unit of a university hospital (200-210 dialysis patients), following 35 patients (15 at home, 20 in the center, 10 on daily dialysis). Opinions were collected with a questionnaire and features identified were empirically tested through a simulation model. Most patients (34/35) preferred a small unit, with a stable caring team. Further options were flexibility of dialysis schedule, multiple treatment options, integrated center/home care. These needs could be met by a flexible organization including conventional dialysis (3/week) and daily dialysis (6/week). We employed a simulation model (ARENA software) to calculate the nurses required for each shift and the opening hours and best schedule for the unit. Addition of daily dialysis (2-3 hours) to two conventional 4-5 hour sessions to increased the number of patients followed or "spared" beds, ensuring flexibility. According to patients' best choice (7 dialysis stations), and to the recorded calls, the needs are for two nurses per shift, two shifts per day and six nurses for up to 30 patients in limited care. In conclusion, small centers with flexible schedules can tailor dialysis to patients' needs. A managerial approach is valuable for testing cost/benefit ratios in specific contexts.
[Costs of dialysis in hospitalised patients with acute or chronic renal failure, according to area of treatment].
BACKGROUND: In Italy, dialysis reimbursement is regulated by the "Tariffario delle prestazioni ambulatoriali" (G.U. N 216, 14/9/1996), which does not take into account separately the dialysis sessions performed in hospitalised patients. In these cases the dialysis activity is considered within the final DRG (Diagnosis Related Group). Aim of the study was an analysis of production costs of dialysis performed in hospitalised patients, according to the setting in which dialysis is performed (Intensive Care Units (ICUs), other Units, hospital dialysis ward). METHODS: The direct production costs were assessed by the "bottom-up" technique logic (cost definition from the single elements needed for producing the treatment) referring to specific Cost Centres. The main items considered were health-care staff, dialysis supplies and hardware, blood tests, dialysis data recording and transmission. RESULTS: During the year 2000, there were 4,450 treatments performed in 490 patients. They included 924 haemodialyses in ICUs; 2,531 in the nephrology hospital dialysis ward; 602 peritoneal dialysis treatments in ICUs-other wards, 393 in the nephrology ward. Direct cost per haemodialysis treatment ranged from 276.05 E (UF) to 413.46 E (HF) in ICU, from 170.47 E (Bicarbonate Haemodialysis) to 275.36 E (Slow Haemofiltration) in hospital dialysis ward; for peritoneal dialysis between 128.95 E (CAPD in dialysis ward) and 282.10 E (CAPD in ICU/other Units). During the year 2000, the global cost of production was 1,038,346.65 E. CONCLUSIONS: The cost of dialysis in hospitalised patients is high. A dedicated budget is needed to avoid deficits, particularly in highly specialised Units of large referral hospitals.
[Analysis of urinary sediments in a nephrological laboratory: a precious art but too expensive?].
Explore the source record for details and available documents.